␤-Catenin-mediated signaling can be constitutively activated by truncation or mutation of serine and threonine residues in exon 3. 
. Finally, we examined the kinase activity of IB kinase-␣ and found that this kinase, unlike glycogen synthase kinase-3␤, appears to preferentially phosphorylate Ser 45 and Thr 41 , independent of priming by casein kinase-1. We conclude that these sites may represent an alternative (non-wnt) signaling pathway, which may be inappropriately activated in tumors with mutations of these residues.
␤-Catenin is a multifunctional protein, participating in both cadherin-mediated adhesion and the wnt signaling cascade. To stabilize cell-cell adhesion, ␤-catenin provides a necessary link between cadherin molecules and the ␣-catenin-based linkage to the actin cytoskeleton, contributing structural integrity to the complex (1, 2) . When ␤-catenin is released from the adhesive complex, it participates in the wnt signaling pathway and possibly other signal transducing functions (3) .
Normal wnt signaling begins when the wnt ligand binds its receptor, Frizzled, which leads to activation of the cytoplasmic protein Dishevelled. Dishevelled, possibly through Frat-1 (frequently rearranged in advanced T-cell lymphoma)/GSK3␤ 1 -binding protein, inactivates the serine/threonine kinase GSK3␤. Inactivated GSK3␤ allows a non-phosphorylated pool of ␤-catenin to accumulate in the cytosol, translocate to the nucleus, and act as a cofactor for the T-cell factor/lymphoid enhancing factor transcription factors. Downstream genes of ␤-catenin activation include cyclin D1, c-myc, CD44, BMP-4, MMP-7, c-jun, and others (2, 4) . In the absence of the wnt signal, GSK3␤ complexes with adenomatous polyposis coli, axin, and casein kinase-1 (CK1) bind ␤-catenin and facilitate its phosphorylation at key serine and threonine residues: Ser 33 , Ser 37 , Thr 41 , and Ser 45 . This phosphorylation event is essential for ␤-catenin binding to ␤-TRCP, an F-box protein associated with ubiquitin-protein isopeptide ligase, which leads to destruction of ␤-catenin by proteasome-mediated degradation. ␤-Catenin can avoid degradation, independent of wnt signaling, if members of the signaling pathway or ␤-catenin does not function normally. Indeed, mutations of adenomatous polyposis coli in colon cancer have been widely reported (2) . Axin mutations have also been reported in ovarian carcinoma, medulloblastoma, colon, and hepatocellular cancers (5) (6) (7) (8) .
Mutations in ␤-catenin have been identified in a variety of benign and malignant human tumors. Alterations to the ␤-catenin gene are primarily point mutations in exon 3. Exon 3 is considered the hot spot for mutations because it contains the key serine and threonine residues phosphorylated by GSK3␤ and other kinases. However, the mutation spectrum of ␤-catenin is not limited to serine and threonine residues, but includes other adjacent residues (see Fig. 1 ). 2 Previously, it was supposed that any mutation in exon 3 could lead to equivalent stabilization of ␤-catenin and transcriptional activation of wnt target genes. However, recent evidence has demonstrated that the serine and threonine residues of ␤-catenin are phosphorylated differentially by CK1 and GSK3␤. CK1␣ and CK1⑀ have been shown to phosphorylate ␤-catenin at Ser 45 , acting as a priming mechanism for GSK3␤ (9) . Without CK1 phosphorylation of Ser 45 , phosphorylation of the remaining Ser 33 , Ser 37 , and Thr 41 sites by GSK3␤ is greatly reduced, as is appropriate degradation of ␤-catenin. These data indicate an important differential role of individual residues in ␤-catenin (9) .
In a parallel pathway, protein kinase A (PKA) has been identified as part of the priming mechanism for ␤-catenin (10). PKA acts distinctly from the CK1-axin-GSK3␤ complex, oper-* The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. ating instead through a presenilin-GSK3␤-␤-catenin complex. This presenilin model of ␤-catenin regulation was shown to be independent of wnt regulation. Therefore, it represents another route cells use to regulate ␤-catenin, exclusive of the canonical wnt pathway, but still through GSK3␤ (10) .
In addition to CK1, PKA, and GSK3␤, phosphorylation of ␤-catenin has been demonstrated with IB kinase (IKK)-␣ and IKK␤ both in vitro and in vivo (11) . IKK␣ localizes in the nucleus in IKK␤-null cells, whereas IKK␤ localizes to the cytoplasm and nucleus in IKK␣-null cells, perhaps indicating different compartmentalization of these kinases. Furthermore, IKK␤ decreases ␤-catenin-dependent transcriptional activity, whereas IKK␣ increases ␤-catenin-dependent transcriptional activity. These results suggest that differential behavior of ␤-catenin with IKK␣ and IKK␤ may contribute to cellular localization of ␤-catenin and its signaling abilities (11) .
Based on the pattern of mutations in benign and malignant human lesions and the ability of ␤-catenin to be differentially phosphorylated by CK1, PKA, IKKs, and GSK3␤, we hypothesized that individual mutations might confer different transforming effects in normal cells. Specifically, we tested the serine and threonine residues most commonly mutated in exon 3 Site-directed Mutagenesis-Mutants were generated using two different kits. Mutants S45A and S33A were made with the MORPH site-specific plasmid DNA mutagenesis kit (5 Prime 3 3 Prime, Inc., Boulder, CO). Mutants T41A and S37A were produced using the QuikChange PCR-based mutagenesis kit (Stratagene, La Jolla, CA). The template for mutagenesis reactions in both kits was full-length wild-type ␤-catenin in pcDNA3 (Invitrogen) with a FLAG tag directly upstream of the ␤-catenin start codon. Mutants were confirmed by direct sequencing (Keck Foundation Biotechnology Resource Laboratory, Yale University). All target codons were changed to alanine. Following confirmation of the sequence, mutant plasmids were transformed into DH5␣ bacteria. Large preparations of plasmids for transfection were generated using maxi-prep kits (QIAGEN Inc., Valencia, CA).
Stable Cell Lines-Subconfluent MDCK cells were transfected with LipofectAMINE 2000 (Invitrogen) on 10-cm plates with 2 g of DNA and 6 l of LipofectAMINE 2000. 2 days post-transfection, the cells were split 1:20, and growth medium containing 500 g/ml G418 (Invitrogen) was added. Cells were selected in G418 for 10 -12 days. Colonies were picked using colony rings, and candidate clones were screened by immunohistochemistry and Western blotting. Clones were maintained in G418-supplemented growth medium to prevent loss of expression of the gene over multiple passages of the clones.
Extraction and Western Blotting-A Triton lysate (20 mM Tris-HCl (pH 8.0), 5 mM EDTA, 150 mM NaCl, 1% glycerol, and 1% Triton X-100) of cultured stable cells was made 3 days post-plating on 6-well Falcon plates (BD Biosciences). Lysate concentration was measured using BioRad reagent, and 20 -40 g of total lysate was loaded onto 15-cm 6% SDS-polyacrylamide gels run at 15°C for 6 h. Gels were transferred in high glycine transfer buffer (25 mM Tris-HCl/glycine (pH 8.0) and 20% methanol) to 0.45-m Hybond nitrocellulose membrane (Amersham Biosciences) on the Genie transfer apparatus (Idea Scientific, Minneapolis, MN). Membranes were blocked in 1% bovine serum albumin (BSA), Tris-buffered saline (TBS), and 0.5% Tween (BSA/TBS/Tween) for 30 min. Primary antibody, either anti-FLAG (M2, Sigma) at 1:1000 dilution or anti-␤-catenin (Transduction Laboratories) at 1:10,000 dilution, was added to fresh BSA/TBS/Tween and incubated at room temperature for 1 h. Following washing with TBS/Tween, horseradish peroxidase-conjugated goat anti-mouse secondary antibody (Pierce) was incubated with the blots at 1:40,000 dilution in TBS/Tween for 45 min. Detection of bands was done with ECL reagent (Amersham Biosciences) and exposure to film. Exposures were taken in the linear range of the reagent signal.
RNA and Northern Blotting-RNA was made by CsCl purification. Briefly, 80 -100% confluent cells in T-75 flasks were lysed with 4 M guanidine thiocyanate and 25 mM sodium acetate (0.45-m filter; Nalgene, Rochester, NY). Lysate was applied to a 5.7 M CsCl and 25 mM sodium acetate cushion (0.45-m filter; Nalgene) in polyallomer centrifuge tubes (14 ϫ 89 mm; Beckman Coulter, Jersey City, NJ). Samples were spun in an SW 40.1 ultracentrifuge at 28,000 rpm for 16 -18 h at 20°C. The following day, pellets of RNA were washed twice with 1 mM EDTA, 10 mM Tris-HCl (pH 7.4), and 0.1% SDS; ethanol-precipitated; and resuspended in diethyl pyrocarbonate/water. The RNA solution was quantitated at 260 nm on a spectrophotometer; and 15 g was added to 25 l of loading buffer, boiled, chilled, and loaded onto a 0.6% denaturing RNA gel. Gels were run in 20 mM MOPS (pH 7.0), 5 mM sodium acetate, and 1 mM EDTA for 4 h. Gels were transferred, top down, with alkaline transfer buffer (3 M NaCl, 8 mM NaOH (pH 11.4), and 0.2 mM Sarkosyl) for 2 h onto Duralon-UV membrane (Stratagene). Following transfer, the membrane was neutralized with 0.2 M sodium phosphate buffer (pH 6.7) and UV-cross-linked (Hoefer Scientific Instruments). Membranes were prehybridized at 68°C for 1 h in ExpressHyb (Clontech, Palo Alto, CA) and 10 g/ml salmon sperm DNA (Stratagene). [
32 P]dCTP-radiolabeled ␤-catenin, cyclin D1, or actin probe (isolated from plasmid DNA) was generated using Ready-To-Go DNA labeling beads (Amersham Biosciences). The probe was boiled and added to the prehybridization solution at 1-2 ϫ 10 6 counts/ml. The blots were hybridized for 1 h at 68°C, washed three times at room temperature with 2ϫ SSC and 0.05% SDS and twice at 55°C with 0.1ϫ SSC and 0.1% SDS, and exposed to film for 1-24 h at Ϫ80°C.
Quantitation of Bands on Gels-Gels were quantitated using TotalLab 1-D analysis software (Non-Linear Dynamics, Durham, NC). The densities of bands were measured in pixel concentration and are given in arbitrary units. For quantitation of Western blots, samples were run in triplicate, and S.E. was calculated.
Immunohistochemistry-MDCK stable cells were grown on fourchamber slides (BD Biosciences) and fixed 48 h post-plating with fresh 4% paraformaldehyde and TBS. Cells were permeabilized with 0.5% Triton X-100, blocked in 1% BSA and TBS, and then exposed to primary antibody in 1% BSA and phosphate-buffered saline (PBS) (Invitrogen). The anti-␤-catenin antibody was an in-house polyclonal antibody (YR6) and was used at 1:500 dilution. The anti-FLAG antibody was monoclonal antibody M2 and was used at 1:1000 dilution. The secondary antibodies were Goat-Anti Rabbit-Alexa 488 (␤-catenin) and Goat Anti Mouse-Cy3 (FLAG-tagged ␤-catenin) (Amersham Biosciences). Secondary antibodies were diluted in TBS/Tween. Cells were mounted in Immunomount medium (Shandon, Pittsburgh, PA). Cells were visualized using fluorescence microscopy. Pictures were taken at a magnification of ϫ200.
Soft Agar Assay-Cells (5000 cells/well) were suspended in Dulbecco's modified Eagle's medium, 5% fetal bovine serum, 1% agarose, and PBS and plated onto 6-well Falcon plates previously coated with 0.6% agarose cushions. After gelling for 20 min, MDCK growth medium was added and changed every 2-3 days for 14 days. Cells were stained with 0.005% crystal violet and 95% ethanol for 1 h at room temperature. Pictures of multiple fields of colony formation were photographed, and the number of colonies was counted using NIH Image. Six fields were counted for each assay; S.E. was generated; and clones were tested against the vector by Student's t test using Prism software (GraphPAD, San Diego, CA). Following image capture, soft agar cushions were fixed in buffered Formalin and paraffin-embedded overnight. Blocks were sectioned and hematoxylin/eosin-stained, and pictures were taken under a magnification of ϫ400 on an inverted microscope.
Three-dimensional Collagen I Assay-Rat tail collagen I was obtained from BD Biosciences. Briefly, a collagen I matrix (final concentration of 2.2-2.4 mg/ml) was made by mixing 10ϫ Dulbecco's modified Eagle's medium and 0.02 N acetic acid to volume, and the pH was adjusted to 7.4 with 1 M NaOH. Immediately, stable cells, previously trypsinized, washed, and pelleted, were resuspended at 500,000 cells/ml in collagen I solution. The collagen I cell suspension was dripped onto p60 Falcon Petri dishes (BD Biosciences) and allowed to set at 37°C in 5% CO 2 for 20 min. Complete medium was gently added and changed every 2 days for 8 days. On day 8, collagen I droplets were removed with forceps, fixed in Formalin, embedded in paraffin, sectioned, and hema-toxylin/eosin-stained. Pictures were taken on a dissecting microscope at a magnification of ϫ100.
Aggregation Assay-Calcium-dependent aggregation of clones was measured. 90% confluent cells on 10-cm Falcon tissue culture dishes (BD Biosciences) were trypsinized in 1% trypsin for 15 min at 37°C in 5% CO 2 with rocking. Cells were collected in Hank's balanced salt solution (Invitrogen) and spun at 1200 rpm to pellet the cells. Cells were resuspended in fresh Hank's balanced salt solution and passed 10 times through a 23-gauge needle to create a single cell suspension. Cells were counted on a Z series Coulter Counter (Beckman Coulter), and 600,000 cells/ml were resuspended either in Hank's balanced salt solution, 1% BSA, and 5 mM CaCl 2 or in Hank's balanced salt solution and 1% BSA without CaCl 2 . On 24-well Falcon plates (BD Biosciences), 0.5 ml of cell suspension was plated and rocked for 3 h at 175 rpm in a 5% CO 2 incubator at 37°C. After 3 h, cells were fixed with buffered Formalin and spotted onto positively charged glass slides (VWR, West Chester, PA). Cells were air-dried and stained with hematoxylin/eosin. Cell aggregates were then counted (1000 total particles/well), and the percentage of cells in clumps of more than three cells was assessed. Assays were run in triplicate, and Student's t tests were performed using Prism software.
Growth Curve-Cells were plated at 300,000 cells/well on 12-well Falcon plates (BD Biosciences) and fed every 2nd day. On days 1, 3, 5, 7, 9, 11, and 13, cells were washed with PBS, and 0.25 mg/ml trypsin/ EDTA was added to each well. Cells were resuspended to a single cell suspension in growth medium to quench trypsin. They were then read on the Z Series Coulter Counter. Each time point was plated in triplicate. S.E. was calculated for each time point, and Student's t tests were carried out using Prism software to determine significance.
Cell Shedding Assay-On day 12 of the growth curve, cells were washed thoroughly with PBS, and 1 ml of growth medium was added. 24 h later, the shed cells were collected and read on the Coulter Counter as described for the growth curve. Each cell line was read in triplicate, and Student's t tests were performed using Prism software to evaluate the significance.
Wounding Assay-6-well Flacon plates were prepared for wounding assays by scoring the plates with a needle so that wounds could be oriented for photographs. After scratching the plates, they were washed with PBS to remove any debris. 1.5 ϫ 10 6 cells were plated in triplicate and allowed to adhere for 12-16 h at 37°C in 15% CO 2 . Cells were wounded with a disposable pipette tip, and pictures were taken at 0, 2, 4, 6, 8, and 10 h. The change in area over 10 h was measured using NIH Image, and Student's t tests were conducted using Prism software.
Kinase Assay-Hemagglutinin-tagged IKK␣ was transfected into COS cells, and extracts were immunoprecipitated with the antibody directed against the hemagglutinin epitope. Immunopurified IKK␣ was added to kinase buffer containing 10 Ci of [␥-32 P]ATP, 1 mM ATP 1 mM dithiothreitol, 5 mM MgCl 2 , 100 mM NaCl, and 50 mM Tris-HCl (pH 8.0). The kinase assays were performed in the presence of 5 g of bacterially expressed GST fusion protein consisting of wild-type ␤-catenin, ␤-catenin-(1-91), ␤-catenin-(1-30), ␤-catenin-(1-56), or ␤-catenin-(1-68). After incubation at 30°C for 15 min, the reactions were mixed with protein sample buffer, heated at 90°C, and loaded onto a 12% SDSpolyacrylamide gel. The phosphoprotein products were visualized by autoradiography.
RESULTS

Spectrum of Mutations of Individual Residues in Exon 3 of ␤-Catenin in Human
Tumors-␤-Catenin mutations in human malignancies occur with widely varied frequency in different tumor types. To assess the spectrum of mutations reported in the literature, studies reporting mutations detected by singlestranded conformational polymorphism and/or direct sequencing from human tumors were recorded. Each time a residue was reported as changed, it was tallied without respect to the residue it was changed to or the number of point mutations detected per patient tumor. Therefore, the number of mutations reflects the number of times a particular mutation was reported as altered in the literature.
Some (Fig. 1A) . Interestingly, Asp 32 , which is not a residue that can be phosphorylated, is more commonly mutated than Ser 33 , one of the recognized GSK3␤ sites. All of the residues on the graph had an incidence of more than five reports in the literature. (Fig. 1, A  and B) . Epithelial tumors and non-epithelial tumors differ most markedly at Thr 41 , which is less frequently altered in non-epithelial lesions (Fig. 1, C and D) . Ser 37 mutants are the most frequent overall, but do not appear to be correlated with either class of malignancy.
Closer examination of the spectrum of mutations in epithelial tumors suggests that mutation profiles may be tissuespecific (Fig. 2, A-D Given the range of mutations seen and the varied tumor behaviors associated with these mutations, we hypothesize that individual mutations differentially act on ␤-catenin-mediated signaling pathways, resulting in diverse biological functions. To assess this possibility, we generated a series of point mutations of the most commonly mutated serine and threonine residues by alanine scanning.
Generation of MDCK Stable Cells Lines with Mutant ␤-Catenin and Its Localization-Stable cell lines were generated in MDCK cells, a nontransformed epithelial cell line with intact cadherin and wnt signaling components. To discern wild-type from mutant ␤-catenin constructs, mutants were FLAGtagged. To detect the relative amounts of FLAG-tagged to endogenous ␤-catenin, total cell lysates were run on 6% gels to separate the 92-kDa endogenous ␤-catenin from the 94-kDa FLAG-tagged ␤-catenin mutants (Fig. 3, left panels) . The relative abundance of each band was quantified in triplicate and is represented in arbitrary units (Table I) .
Because S45A has more FLAG-tagged ␤-catenin compared with endogenous ␤-catenin and S33A has less FLAG-tagged ␤-catenin compared with endogenous ␤-catenin, we wondered if these differences were due to expression of the ␤-catenin mutants or if they were due to post-transcriptional events such as protein turnover. Northern blot analysis demonstrated that gene expression levels mirrored protein expression levels (Fig.  3, right panels; and Table I ). This suggests there is not a dramatic difference in the degradation rate of the protein.
Equal loading of Northern blots was assessed by blotting with actin (data not shown).
It was expected that stabilization of ␤-catenin would lead to nuclear translocation and that the FLAG-tagged mutants would be detectable in the nucleus. Previously, we have shown that transient overexpression of these point mutants in MDCK cells leads to nuclear localization and speckling in the nucleus (12) . Although we have shown dramatic nuclear localization in transients, stable expression in cell lines of these four clones demonstrated no evidence of nuclear localization. Repeated attempts to create stable lines with overexpression of the wildtype construct failed to produce cells that were sustainable in culture. One clone, which at first appeared useful, had metabolic problems in assays for Ͼ3 days. This inability to create a wild-type ␤-catenin-overexpressing clone was repeated by two researchers. It is believed that, in this strain of MDCK cells, overexpression of wild-type ␤-catenin is toxic. A neomycinresistant clone without FLAG-␤-catenin integration was used as a vector control for experiments to determine the effects of endogenous ␤-catenin in MDCK cells.
In the MDCK stable cells, all four constructs localized to the membrane with some heterologous cytoplasmic staining (Fig.  4) . In subconfluent cells, stronger cytoplasmic staining was seen (data not shown); but at confluence, FLAG staining demonstrated that all of the mutants could localize to the membrane. In confluent cultures, when cytoplasmic staining was detected, there was frequently an enlargement in the cell morphology, and the cell appeared to be crawling over the monolayer, with cytoplasmic extensions visible. Phase images and 4,6-diamidino-2-phenylindole staining of these cells revealed that these cells had intact nuclei. In contrast to the FLAG staining in mutants, vector-only cells exhibited perinuclear, nonspecific background staining in both subconfluent (data not shown) and confluent cells. Cells growing on top of one another or with enlarged morphology and cytosolic projections were never observed in vector control cells.
A Basic Level of Transformation Is Observed in All Constructs as Assayed by Anchorage-independent Growth and by
Growth in Collagen I-All of the mutants were capable of anchorage-independent growth in soft agar (Fig. 5, A and B) . The structures of the colonies that formed in soft agar were assessed by hematoxylin/eosin staining of the colonies in crosssection. Vector-only colonies formed small compact balls of polarized cells. Each of the mutant cell lines formed complex cystic structures consisting of multicellular arrangements. All of the clones formed significantly more colonies than the vector when quantified, demonstrating that each serine or threonine mutant was capable of anchorage-independent growth (Fig. 5B ).
MDCK cells demonstrate three-dimensional cystic growth in collagen I (13, 14) . Cells were grown for 8 days suspended in collagen I, fixed, sectioned, and stained to evaluate colony morphology. Similar to the growth in soft agar, non-transfected MDCK cells formed small, tight, compact colonies, whereas each of the mutants formed larger cystic structures with architecture that was similar among all four of the clones (Fig. 5A) .
Since all of the mutant forms of ␤-catenin localized at the membrane (Fig. 4) , we evaluated the ability of these clones to form aggregates. No statistically significant difference was observed in any of the mutant's ability to participate in calciumdependent aggregation compared with the vector (Fig. 5C) . Additionally, each of the serine/threonine mutants was able to coprecipitate with members of the junctional complex, Ecadherin and ␣-catenin (data not shown). We conclude from these data that mutations of Ser 45 , Thr 41 , Ser 37 , or Ser 33 do not disrupt the cadherin-catenin complex or normal cell aggregation.
Ser 45 and Thr 41 Promote Proliferation at High Cell Densities-Contact inhibition at confluence is a property of normal cells. Transformed cells may lose their ability to stop growing once confluence is achieved. Growth curve and cell shedding assays were conducted to assess the ability of the stable mutant ␤-catenin cell lines to overcome contact inhibition. During the exponential growth phase (Fig. 6A) , only S33A showed a sig- nificant decrease in growth rate, indicating that mutations of Ser 45 , Thr 41 , and Ser 37 do not play a role in the rate of cell growth. However, in the steady-state phase of growth, S45A and T41A had increased numbers of cells present (Fig. 6B ) compared with vector-transfected cells. S37A and S33A had significantly fewer cells present at confluence. To determine whether the cells were still actively dividing in the steady-state phase of the growth curve, a cell shedding assay was conducted.
Cell shedding is another measure of proliferation at high cell density (Fig. 6C) . On day 13 of the growth curve, when the cells reached steady-state confluence, the number of cells shed over 24 h was evaluated. Again, S45A and T41A shed significantly more cells, whereas S37A and S33A were equivalent to the vector. It is noteworthy that this experiment was consistently reproducible only when the cells had achieved steady-state confluence. To determine whether the shed cells were viable, the assay was conducted on day 13 for 6 h, and shed cells were replated. The replated cells did not attach to the plate or grow (data not shown). Thus, the mutations do not confer viability in suspension when shed from the monolayer, but rather reflect a continued production and turnover of the monolayer in confluent cells. Although no nuclear ␤-catenin was detected in the stable cells (Fig. 4) , it appears that a proliferation response exists in the cells expressing Ser 45 and Thr 41 mutants of ␤-catenin. Cyclin D1 is a potential target gene of ␤-catenin activation and a regulator of the cell cycle (15 3 . Left panels, Western blot (WB) analysis of endogenous ␤-catenin (␤-cat) and FLAG-tagged mutant ␤-catenin. 6% SDS-polyacrylamide gels separated FLAG-tagged from endogenous bands in Triton lysates (20 g ). The upper band (94 kDa) is FLAG-␤-catenin (Flag), and the lower band (92 kDa) is endogenous ␤-catenin (Endog). In vector (VEC)-transfected cells, only the lower endogenous band was present. Triton lysates (40 g) were also Western-blotted with anti-FLAG antibody, and the results show FLAG-␤-catenin detection in all of the stable point mutant clones, but not in the vector-only cells. Right panels, Northern blot (NB) analysis of total RNA for ␤-catenin and FLAGtagged constructs. The upper band represents the doublet of endogenous ␤-catenin. It is the only band present in the vector-only lane. In all of the cell lines, a lower band representing the FLAG-tagged constructs is also evident. The membrane was reprobed with actin to demonstrate equal loading.
TABLE I Ratios of FLAG-tagged to endogenous ␤-catenin in stable clones
The ratios of FLAG-tagged mutant ␤-catenin to endogenous ␤-catenin for each stable clone are shown. For RNA, a single blot was analyzed using TotalLab 1-D software. For protein, triplicate Western blots were analyzed using TotalLab 1-D software. ences (data not shown), but Northern blotting revealed that S45A had 3-fold the amount of cyclin D1 RNA present. Increased expression of cyclin D1 in the S45A cell line may contribute to its increased growth at confluence (Fig. 7) . Blots were normalized to the 28 S band. Ser 45 Mediates Increased Migration after Wounding of the Monolayer-In vivo, cells exist as confluent sheets undertaking remodeling during growth and development or in cancer cells when invading or metastasizing. Measuring a cell's ability to repair when the monolayer is wounded measures the invasive and migratory potential of the cell (16) . Stable ␤-catenin cell lines were analyzed 10 h post-wounding, and the migratory front of the wound was measured to evaluate migration into a cell-free area. Only S45A showed a modestly significant increase in wound closure compared with the other clones (Fig. 6D) . Summarizing the mutation data in the literature and all of our functional assays, there appears to be two groups or classes of sites. The Ser 45 and Thr 41 mutants show generally more aggressive behavior compared with the Ser 37 and Ser 33 mutants.
IKK␣ Phosphorylation Sites Preferentially Phosphorylate
Ser 45 or Thr 41 -Although GSK3␤ kinase is thought to be the primary kinase of canonical wnt signaling, recent reports have indicated that other kinases may be involved in regulation of phosphorylation of ␤-catenin. Specifically, CK1 was recently shown to phosphorylate ␤-catenin at Ser 45 , priming the remaining sites for phosphorylation by GSK3␤ (9) . The effect of various mutations on phosphorylation by GSK3␤ and CK1 has been shown by a number of groups (9), but to our knowledge, this has not been done with the IKKs. We found that IKK␣ was able to phosphorylate ␤-catenin mutated at Ser 37 and Ser 33 , either individually or in combination (Fig. 8) . However, mutation of Ser 45 or Thr 41 abolished the ability of IKK␣ ability to phosphorylate ␤-catenin. This was seen most severely in constructs with mutation of both Ser 45 and Thr 41 . Thus, IKK␣ appears to match the functional grouping seen in the studies above. In contrast to the results with IKK␣, IKK␤ did not preferentially phosphorylate Ser 45 or Thr 41 , but other downstream residues in the amino terminus of ␤-catenin.
FIG. 4.
Immunofluorescence of ␤-catenin and FLAG-tagged ␤-catenin mutants in stable cells. Vector-only cells showed strong membranous staining when stained with anti-␤-catenin polyclonal antibody. FLAG staining in vector-only cells was at background levels and was perinuclear. S45A, T41A, S37A, and S33A all demonstrated a membranous pattern of FLAG staining in addition to heterologous cytoplasmic staining. This pattern was stable over multiple passages. Cytoplasmic FLAG staining colocalized with cytoplasmic ␤-catenin (␤-cat) staining.
FIG. 5.
A, soft agar assay. Colonies grown for 14 days in soft agar and Formalin-fixed, paraffin-embedded, and sectioned were hematoxylin/ eosin-stained. Vector (VEC)-transfected cells demonstrated small compact colonies, whereas all mutants showed a complex architecture with cystic structures. Magnification is ϫ400. B, collagen I Assay. Cells were grown in rat tail collagen I for 8 days and assessed for cystic architecture. Non-transfected cells showed small structures, whereas the mutants all showed larger cysts with hollow centers. All of the mutants had the similar structure of the collagen I-induced cysts. Magnification is ϫ100. C, quantitation of colony formation in soft agar. All of the stable mutant cell lines were able to form colonies in a statistically significant way compared with vector-only cells as determined by Student's t test. D, aggregation assay. The percent of calcium-dependent aggregation showed that all of the mutants were non-significant compared with vector-only cells as determined by Student's t test.
DISCUSSION
␤-Catenin is an oncogene that is mutated in both malignant carcinomas and benign lesions. Exon 3 of ␤-catenin, the hot spot for ␤-catenin mutations, contains six predominant mutations. Four of these mutations are of the serine and threonine residues, Ser 45 , Thr 41 , Ser 37 , and Ser 33 , which are phosphorylated during regulation of ␤-catenin stability. Although previous investigators have deleted all of the serine and threonine sites together to study the effects of stable ␤-catenin on cellular transformation, we looked at common serine and threonine mutations individually to assess the transforming ability in MDCK cell lines. We found that all of the mutants contained some level of transforming ability as assayed by growth in soft agar and in collagen I. However, in assays for proliferation, migration, and downstream target transcriptional activation, two classes of mutations emerged. S37A and S33A stable cell lines showed a decrease in cell density at confluence, whereas T41A and S45A demonstrated a significant increase in the number of cells present in the steady-state phase of growth. In addition, S45A demonstrated increased migration after wounding of the monolayer. Finally, cyclin D1, a downstream effector of ␤-catenin activation, showed an increase in RNA levels in S45A cells, although no difference was detectable at the protein 6 . A, quantitation of the rate of growth of cell lines in the exponential growth phase of the growth curve. Only S33A showed a significant decrease in growth rate compared with the vector as determined by Student's t test. Each time point was taken in triplicate, and two independent experiments were averaged for cell growth rate/h in the log phase of the growth curve (days 2-9). B, cell density at confluence. In the steady-state phase of the growth curve, S45A and T41A had increased cell density compared with vector-only cells. S37A and S33A were significantly less confluent compared with vector-only cells. Each time point was taken in triplicate, and two independent experiments were averaged. C, cell shedding. In the steady-state phase of the growth curve, S45A and T41A shed more cells into their media compared with the vector. S37A and S33A did not shed at a significantly altered rate. Each cell line's shed cells were collected in triplicate, and two independent experiments were averaged. D, wounding assay. Cells were evaluated for their ability to migrate into a cell-free area following physical disruption of the monolayer. Only S45A showed statistical significance as determined by Student's t test. Each wounding assay was preformed in triplicate.
level. Together, these data demonstrate that individual mutations in ␤-catenin result in differential behavior of cells harboring the mutations in transformation assays.
Prior to this work, Orford et al. (17) examined the effects of overexpression of wild-type and stable Ser 37 mutant ␤-catenin. They found that both overexpressed wild-type and Ser 37 mutant ␤-catenin resulted in increased anchorage-independent growth, proliferation, and altered G 1 -to-S phase transition that protected cells from suspension-induced anoikis. Our results are largely similar to those obtained by Orford et al. (17) . However some differences may be attributable to differences in strains of MDCK cells (17) .
Although MDCK cells were chosen for their ease of transfection and because they are nontransformed epithelial cells, a potential drawback of the system is the presence of endogenous normal ␤-catenin. Biologically, the presence of wild-type ␤-catenin more closely reproduces the environment of cells harboring mutations in human tumors. In human samples, ␤-catenin mutations are sporadic and generally affect only one allele. Mutant sequence traces from human tissue frequently show mixed results at the mutation site, demonstrating the coexistence of wild-type and mutant ␤-catenin in vivo (18) . Therefore, we believe the heterozygous expression of ␤-catenin in MDCK cells in a reasonable model for human tumors.
When fingerprints were generated for individual cancers, different mutation spectrums were observed. These profiles may be due to tissue-specific events favoring particular mutations. In rat models of colon cancer, selection of Ser 45 and Thr 41 occurs after exposure to cancer-inducing chemicals. Ser 45 and Thr 41 are further selected in later stage tumors, as opposed to early mutation profiles that show even distribution between the serine and threonine residues (19) . Likewise, selective pressures may favor mutation at one residue over another based on the pathway that is dysregulated. As multiple kinases and alternative pathways emerge for ␤-catenin regulation, it is possible that the relative importance of these pathways in individual cell types will play a role in determining the selection of mutations in certain tumors.
Exon 3 of ␤-catenin contains several consensus sequences for various kinases (Fig. 9) . CK1, CK2, GSK3␤, and IKKs have consensus sequences encompassing the critical serine and threonine residues. PKA, which has been suggested to prime ␤-catenin at Ser 45 in a presenilin-GSK3␤ complex, does not have a consensus sequence including Ser 45 or any residues in exon 3. This makes it likely that the effects of PKA on phosphorylation of ␤-catenin at Ser 45 are due to mechanisms other than direct phosphorylation by PKA.
To date, the serine/threonine kinases suggested to regulate ␤-catenin include CK1 and PKA, which act in concert with GSK3␤, and IKK␣ and IKK␤. We have demonstrated that disruption of Ser 45 and/or Thr 41 in in vitro kinase assays abolished the ability of IKK␣ to phosphorylate ␤-catenin. Disruption of Ser 37 and/or Ser 33 did not have this effect. Therefore, we conclude that IKK␣-mediated phosphorylation of ␤-catenin requires intact Ser 45 and Thr 41 sites. Furthermore, IKK␣ was able to phosphorylate ␤-catenin directly in in vitro kinase assays independent of CK1, GSK3␤, or any other priming mechanism. Therefore, phosphorylation by IKK␣ may represent a separate pathway for ␤-catenin regulation that does not require multiple kinase activation or canonical wnt pathway members. Since IKK␣ (but not IKK␤) has been shown to shuttle between the cytoplasm and nucleus (20) , it is possible that IKK␣ phosphorylation of nuclear ␤-catenin can result in changes in the interactions of proteins that bind to ␤-catenin such as p300/CBP (cAMP-responsive element-binding proteinbinding protein) (21) .
Disruption of serine and threonine residues in exon 3 perturbs GSK3␤-adenomatous polyposis coli-axin phosphorylation and breakdown of ␤-catenin, allowing inappropriate stabilization of ␤-catenin and transcriptional activation. Almost all of the recently identified novel kinases that phosphorylate ␤-catenin at key serine and threonine sites have consensus sequences in exon 3 (Fig. 9) . The exception to this is PKA, which has been suggested to prime ␤-catenin at Ser 45 acting in conjunction with presenilin and GSK3␤ (10), but does not have an identified PKA site in exon 3. PKA has been shown to be a negative regulator of GSK3␤ activity, phosphorylating it at Ser 9 , a site associated with negative regulation by protein kinase B/Akt as well. It is unclear how this information fits into the PKA- (26) ; and ubiquitination signal (Ubiq), DSGXS (27) . No consensus sequence was identified for PKA (R(R/K)X(S/T), RXX(S/T), or RX(S/T)) (28, 29) .
presenilin-GSK3␤ story of ␤-catenin regulation, but it may suggest another mechanism by which PKA regulates the GSK3␤-␤-catenin phosphorylation event. CK1, which primes ␤-catenin at Ser 45 , has a consensus sequence of (pS/pT)XXS. CK1 has previously been shown to phosphorylate serines or threonines that are three amino acids downstream of an already phosphorylated serine or threonine (22) . In the case of exon 3, this would be Thr 42 , which would be phosphorylated prior to CK1 phosphorylation of Ser 45 . It is interesting that Thr 42 has been identified only once as mutated in anaplastic thyroid cancer (23) . The relative importance of this residue in CK1 priming then appears more important than its role in disruption of ␤-catenin.
In conclusion, the diversity of kinases and pathways that play a role in ␤-catenin-mediated signaling may be essential in understanding the tissue-specific behavior of ␤-catenin. The fact that IKKs show a unique set of target residues compared with that seen for GSK3␤ and that mutations of those residues define a separate set of biological behaviors suggests that we are just beginning to understand some of the alternative mechanisms of ␤-catenin-mediated signaling. Understanding this diversity may ultimately shed light on the relative contribution of ␤-catenin in specific cancers and define unique targets for therapeutic interruption of oncogenic events.
